259 related articles for article (PubMed ID: 18759301)
1. Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis.
Solus J; Chung CP; Oeser A; Avalos I; Gebretsadik T; Shintani A; Raggi P; Sokka T; Pincus T; Stein CM
Arthritis Rheum; 2008 Sep; 58(9):2662-9. PubMed ID: 18759301
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediator.
Bradham WS; Ormseth MJ; Oeser A; Solus JF; Gebretsadik T; Shintani A; Stein CM
Inflammation; 2014 Jun; 37(3):801-8. PubMed ID: 24402421
[TBL] [Abstract][Full Text] [Related]
3. [N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].
Kirillova IG; Novikova DS; Popkova TV; Aleksandrova EN; Novikov AA; Gorbunova YN; Markelova EI; Korsakova YO; Glukhova SI; Volkov AV; Luchikhina EL; Demidova NV; Kasumova KA; Vladimirov SA; Kanonirova MA; Lukina GL; Karateev DE; Nasonov EL
Ter Arkh; 2016; 88(5):19-26. PubMed ID: 27239922
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study.
Peters MJ; Welsh P; McInnes IB; Wolbink G; Dijkmans BA; Sattar N; Nurmohamed MT
Ann Rheum Dis; 2010 Jul; 69(7):1281-5. PubMed ID: 19934107
[TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-brain natriuretic peptide in systemic lupus erythematosus: relationship with inflammation, augmentation index, and coronary calcification.
Chung CP; Solus JF; Oeser A; Avalos I; Kurnik D; Raggi P; Stein CM
J Rheumatol; 2008 Jul; 35(7):1314-9. PubMed ID: 18528966
[TBL] [Abstract][Full Text] [Related]
7. The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study.
Provan SA; Angel K; Odegård S; Mowinckel P; Atar D; Kvien TK
Arthritis Res Ther; 2008; 10(3):R70. PubMed ID: 18573197
[TBL] [Abstract][Full Text] [Related]
8. Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis.
Targońska-Stępniak B; Majdan M
Clin Rheumatol; 2011 Jan; 30(1):61-9. PubMed ID: 21110214
[TBL] [Abstract][Full Text] [Related]
9. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.
Chung CP; Oeser A; Solus JF; Gebretsadik T; Shintani A; Avalos I; Sokka T; Raggi P; Pincus T; Stein CM
Arthritis Rheum; 2008 Jul; 58(7):2105-12. PubMed ID: 18576352
[TBL] [Abstract][Full Text] [Related]
10. Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.
Nguyen THP; Fagerland MW; Deyab G; Hjeltnes G; Hollan I; Feinberg MW; Eilertsen GØ; Mikkelsen K; Agewall S
PLoS One; 2021; 16(6):e0253793. PubMed ID: 34170978
[TBL] [Abstract][Full Text] [Related]
11. [Level of N-terminal fragment of brain natriuretic peptide progenitor and atherosclerotic damage of brachocephalic arteries in patients with rheumatoid arthritis with inefficiency and/or injurability of basic anti - inflammatory treatment].
Gerasimova EV; Popkova TV; Martynova AV; Markelova EI; Novikova DS; Kirillova IG
Ter Arkh; 2019 May; 91(5):34-39. PubMed ID: 32598674
[TBL] [Abstract][Full Text] [Related]
12. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.
Ndrepepa G; Kastrati A; Braun S; Mehilli J; Niemöller K; von Beckerath N; von Beckerath O; Vogt W; Schömig A
Am J Med; 2006 Apr; 119(4):355.e1-8. PubMed ID: 16564781
[TBL] [Abstract][Full Text] [Related]
13. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
[TBL] [Abstract][Full Text] [Related]
14. Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis.
Welsh P; Tuckwell K; McInnes IB; Sattar N
Atherosclerosis; 2016 Nov; 254():167-171. PubMed ID: 27744141
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism.
Ogard CG; Engelmann MD; Kistorp C; Nielsen SL; Vestergaard H
Clin Endocrinol (Oxf); 2005 Nov; 63(5):493-8. PubMed ID: 16268799
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs.
Ruff CT; Morrow DA; Jarolim P; Ren F; Contant CF; Kaur A; Curtis SP; Laine L; Cannon CP; Brune K
J Rheumatol; 2011 Jun; 38(6):1071-8. PubMed ID: 21459935
[TBL] [Abstract][Full Text] [Related]
17. The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent Heart Failure and Death in Patients with Stable Coronary Artery Disease: The Heart and Soul Study.
Mishra RK; Judson G; Christenson RH; DeFilippi C; Wu AHB; Whooley MA
Cardiology; 2017; 137(4):201-206. PubMed ID: 28445886
[TBL] [Abstract][Full Text] [Related]
18. Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks.
Zoli A; Bosello S; Comerci G; Galiano N; Forni A; Loperfido F; Ferraccioli GF
Rheumatol Int; 2017 Jan; 37(1):13-19. PubMed ID: 26586235
[TBL] [Abstract][Full Text] [Related]
19. Impact of tocilizumab on N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis without cardiac symptoms.
Yokoe I; Kobayashi H; Kobayashi Y; Giles JT; Yoneyama K; Kitamura N; Takei M
Scand J Rheumatol; 2018 Sep; 47(5):364-370. PubMed ID: 29804492
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism.
Folsom AR; Lutsey PL; Heckbert SR; Poudel K; Basu S; Hoogeveen RC; Cushman M; Ballantyne CM
J Thromb Haemost; 2018 Oct; 16(10):1964-1972. PubMed ID: 30007116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
